Merck (MRK) EBT (2009 - 2026)
Merck (MRK) posted quarterly EBT of -$3.5 billion for Q1 2026, down 159.29% year-over-year from $5.9 billion in Q1 2025, and down 202.34% quarter-over-quarter from $3.4 billion in Q4 2025.
Merck (MRK) EBT (2009 - 2026) Analysis & Trends
Merck (MRK) has reported EBT for 18 consecutive years, with -$3.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 159.29% year-over-year to -$3.5 billion; the TTM figure through Mar 2026 stood at $11.7 billion (down 42.17% YoY), while the FY2025 annual figure was $21.1 billion, up 5.67% from the prior year.
- EBT slipped to -$3.5 billion in Q1 2026 per MRK's latest filing, from $3.4 billion in the prior quarter.
- Across five years, EBT topped out at $6.7 billion in Q3 2025 and bottomed at -$5.3 billion in Q2 2023.
- Historically, EBT has averaged $3.3 billion across 5 years, with a median of $4.2 billion in 2024.
- Annual changes were most pronounced in 2023 — EBT slumped 218.9% — and 2024, when it jumped 303.81%.
- Merck's EBT stood at $3.5 billion in 2022, then sank by 158.24% to -$2.0 billion in 2023, then surged by 303.81% to $4.2 billion in 2024, then retreated by 17.99% to $3.4 billion in 2025, then tumbled by 202.34% to -$3.5 billion in 2026.
- Business Quant data shows MRK's EBT at -$3.5 billion in Q1 2026, $3.4 billion in Q4 2025, and $6.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 17.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -683.00 Mn |
| Mar 31, 2026 | -3.50 Bn |
| Dec 31, 2025 | 3.42 Bn |
| Sep 30, 2025 | 6.75 Bn |
| Jun 30, 2025 | 5.00 Bn |
| Mar 31, 2025 | 5.90 Bn |
| Dec 31, 2024 | 4.17 Bn |
| Sep 30, 2024 | 4.09 Bn |
| Jun 30, 2024 | 6.01 Bn |
| Mar 31, 2024 | 5.67 Bn |
| Dec 31, 2023 | -2.05 Bn |
| Sep 30, 2023 | 5.62 Bn |
| Jun 30, 2023 | -5.34 Bn |
| Mar 31, 2023 | 3.65 Bn |
| Dec 31, 2022 | 3.51 Bn |
| Sep 30, 2022 | 3.58 Bn |
| Jun 30, 2022 | 4.49 Bn |
| Mar 31, 2022 | 4.86 Bn |
| Dec 31, 2021 | 3.91 Bn |
| Sep 30, 2021 | 5.27 Bn |